Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases
- PMID: 24716181
- PMCID: PMC3924999
- DOI: 10.4103/2225-4110.119723
Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases
Abstract
Frankincense ( Rǔ Xiāng; Boswellia Species), the resinous extract from the trees of the genus Boswellia, has been used for centuries in cultural ceremonies, as a cosmetic agent, and as a traditional medicine to treat a variety of ailments, especially inflammatory diseases including asthma, arthritis, cerebral edema, chronic pain syndrome, chronic bowel diseases, cancer, and some other illnesses. Boswellic acids are the active compounds of frankincense and AKBA (3-O-acetyl-11-keto-β-boswellic acid) is the most important and effective acid among them. Some studies have shown that the use of frankincense can also improve the learning and enhance the memory in animals and human beings. It seems that frankincense might have a potential ability to be used as an alternative natural medicine not only for chronic and inflammatory diseases but also for brain and memory disorders.
Keywords: Anti-inflammatory; Boswellia species; Cancer; Chronic diseases; Memory enhancement.
References
-
- Afsharypuor S, Rahmany M. Essential oil constituents of two African Olibanums available in Isfahan Commercial Market. Iran J Pharmacol Sci. 2005;1:167–70.
-
- Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. 1997;281:460–3. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
